Drug control of Ara-C-resistant tumor cells.
D015092:3-Deazauridine / Q000008:administration & dosage; D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000880:Anthraquinones / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D008942:Mitoxantrone; D009374:Neoplasms, Experimental / Q000188:drug therapy*
D000880:Anthraquinones; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015092:3-Deazauridine; D003520:Cyclophosphamide; D008942:Mitoxantrone